1 / 9

Veterans Aging Cohort Study (VACS)

Veterans Aging Cohort Study (VACS). Required:. Optional based on other project funding:. Now have support through August 2016 for a total of 20 years of follow up in Virtual Cohort and 16 years for VACS 8. VACS Cohort and Substudies.

taini
Télécharger la présentation

Veterans Aging Cohort Study (VACS)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Veterans Aging Cohort Study (VACS) Required: Optional based on other project funding:

  2. Now have support through August 2016 for a total of 20 years of follow up in Virtual Cohort and 16 years for VACS 8

  3. VACS Cohort and Substudies Virtual Cohort(VC) comprised of national data. Elements include demographics, diagnostic and procedure codes, labs, pharmacy, vital signs… VACS9 is the 9 site consented patient study with richer data. Includes surveys, adjudicated outcomes for cancer, mi, liver disease, site downloaded data VC limited to patients in 2003 or later. Includes adjudicated MI from IHD Queri Includes Ddimer, IL6, sCD14 3 VACS sites only. Includes GXT, CT and echo data

  4. Virtual Cohort (VC) • SUBJECTS: 52,981 HIV infected; 110,349 uninfected • All individuals with HIV diagnoses • Age, race/ethnicity, region 2:1 matched controls • Last updated: September 2015 • Next update: Currently in progress • SITES: All VA sites • BASELINE: 1998 (19 years of follow up) • HIV infected veterans at initiation of HIV care • Controls selected and followed in same calendar year

  5. VACS 9 • CURRENT DATA SOURCES (all VC sources plus) • All VA Electronic medical records including text fields • Sentinel event records (MI) requested outside VA • DNA and tissue bank (subset of 2,300 patients) • Self completed surveys (health behaviors, quality of life, symptoms, outside utilization, etc.) every 12-18 months • SUBJECTS: 4,230 HIV infected; 4,446 uninfected • Group matched: age, race/ethnicity, and site • Last updated October 16, 2015 • SITES:Atlanta1, Bronx1, Houston1, Los Angeles1, New York1, Baltimore2†, Washington DC2, Pittsburgh3†, Dallas4, Nashville5 **1. 2002-present, 2. 2003-present, 3. 2003-present, 4. 2012-present, 5. 2015-present †= No longer actively enrolling • BASELINE: 2002 (15 years)

  6. National VACS/COMpAAAS Project Team 2016

  7. COMpAAAS

  8. Acknowledgements • Consortium PI : AC Justice* • Scientific Collaborator (NIAAA): K Bryant • Affiliated PIs: S Braithwaite, C Brandt*, K Crothers*, R Dubrow, DA Fiellin*, M Freiberg*, V LoRe*, K Kraemer, Janet Tate* • Participating VA Medical Centers: Atlanta (V Marconi*), Bronx (S Brown, Y Ponomarenko), Dallas (R Bedimo*), Houston (M Rodriguez-Barradas, N Masozera), Los Angeles (M Goetz), Manhattan-Brooklyn (M Simberkoff, D Blumenthal, H Leaf, J Leung), Nashville (T Holgan, H Murff), and Washington DC (C Gibert, R Peck) • Core and Workgroup Chairs: B Agan, K Akgun, W Becker, E Cartwright, J Edelman, J Goulet, B Gulanski, K McGinnis, KA Oursler, L Park, C Rentsch, C Rinaldo, K Sigel, E Wang, F P Wilson, J Womack • Staff: H Bathulapalli, T Bohan, J Ciarleglio, A Consorte, L Erickson, C Frank, K Gordon, J Huston, F Kidwai-Khan, G Koerbel, F Levin, S Loch, S Shahrir, M Skanderson • Major Collaborators: VA Public Health Strategic Healthcare Group, VA Pharmacy Benefits Management, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Yale Center for Interdisciplinary Research on AIDS (CIRA), Center for Health Equity Research and Promotion (CHERP), Laboratory for Biochemistry Research at the University of Vermont, ART-CC, NA-ACCORD, HIV-Causal • Cross Cohort Collaborators: Richard Moore (NA-ACCORD), Jonathan Sterne (ART-CC), Brian Agan (DoD), Miguel Hernan (HIV-Causal) • Major Funding by: National Institutes of Health: AHRQ (R01-HS018372), NIAAA (U24-AA020794, U01-AA020790, U01-AA020795, U01-AA020799, U24-AA022001, U24 AA022007, R01-AA023733, R01AA022886, U10 AA013566-completed), NHLBI (R01-HL125032, RO1-HL126555,R01-HL095136-completed, R01-HL090342-completed) , NIAID (U01-A1069918), NIDA (R01-DA04071-A1, R01DA035616-completed, R03DA031592-completed) , NCI (R01 CA173754, R01 CA206465) and the Veterans Health Administration Office of Research and Development (i01 BX003341, 1 I50 HX001234, VA IRR Merit Award), Office of Rural Health, and Office of Academic Affiliations (Medical Informatics Fellowship) *Indicates individual is also the Chair of a Core or Workgroup

  9. AcknowledgementsContinued QR Codes QR Code for VACS QR Code for VACS QR Code for VACS Homepage INDEX CALCULATOR- INDEX CALCULATOR- MOBILE APP Other Notable Funding:Career Development Awards: National Institutes of Health: NIDA (1K12DA033312-01A1, 8UL1TR000142) COMpAAAS/Veterans Aging Cohort Study, a CHAART Cooperative Agreement, supported by the National Institutes of Health: National Institute on Alcohol Abuse and Alcoholism (U24-AA020794, U01-AA020790, U01-AA020795, U01-AA020799; U10 AA013566-completed) and in kind by the US Department of Veterans Affairs.  In addition to grant support from NIAAA, we gratefully acknowledge the scientific contributions of Dr. Kendall Bryant, our scientific collaborator.

More Related